Page 46 - French Commercial Code News Today

This text is a free translation from the French language and is supplied solely for information purposes. Only the original version in the French... | May 5, 2023

This text is a free translation from the French language and is supplied solely for information purposes. Only the original version in the French... | May 5, 2023

Daix , Long Island City , May 4, 2023 – Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with... | May 4, 2023

General shareholders’ meeting to be held on May 25, 2023Availability of the documents relating to the general shareholders’ meeting Saint-Cloud, May 4, 2023 - The Combined General... | May 4, 2023

Daix (France), Long Island City (New York, United States), May 4, 2023 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small

France's competition watchdog has announced interim measures on Meta's business following a complaint by a local ad verification company.

PRELIMINARY NOTE The unaudited condensed Consolidated Financial Statements for the three-month period ended March 31, 2023, included herein, have been prepared in... | May 4, 2023

Press release Sensorion provides preliminary documents for the Combined shareholders General Meeting of May 24, 2023 ... | May 3, 2023

Regulatory News: Sensorion (FR0012596468 ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that the Company's shareholders

Article 223-16 of the General Regulations of the Financial Markets Authority (AMF Autorité des Marchés Financiers) Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a clinical-stage